Frank H. Laukien - Apr 24, 2023 Form 4 Insider Report for BRUKER CORP (BRKR)

Signature
/s/ Michael Simone, Attorney-in-Fact
Stock symbol
BRKR
Transactions as of
Apr 24, 2023
Transactions value $
-$16,092,163
Form type
4
Date filed
4/26/2023, 04:17 PM
Previous filing
Dec 19, 2022
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRKR Common Stock Sale -$11.8M -146K -0.38% $81.01 38.4M Apr 24, 2023 Direct F1, F2
transaction BRKR Common Stock Sale -$172K -2.11K -0.01% $81.65 38.3M Apr 24, 2023 Direct F1, F3
transaction BRKR Common Stock Sale -$1.07M -13.8K -0.04% $77.87 38.3M Apr 25, 2023 Direct F1, F4
transaction BRKR Common Stock Sale -$2.4M -30.3K -0.08% $79.06 38.3M Apr 25, 2023 Direct F1, F5
transaction BRKR Common Stock Sale -$573K -7.17K -0.02% $79.82 38.3M Apr 25, 2023 Direct F1, F6
transaction BRKR Common Stock Sale -$37.1K -460 0% $80.64 38.3M Apr 25, 2023 Direct F1, F7
holding BRKR Common Stock 1.05M Apr 24, 2023 By Former Spouse F8
holding BRKR Common Stock 337K Apr 24, 2023 By Son F8
holding BRKR Common Stock 337K Apr 24, 2023 By Daughter F8
holding BRKR Common Stock 202K Apr 24, 2023 As UTMA Custodian for Son
holding BRKR Common Stock 71.7K Apr 24, 2023 As UTMA Custodian for Son
holding BRKR Common Stock 492 Apr 24, 2023 By Former Spouse F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.57 to $81.52, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.585 to $81.93, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.51 to $78.45, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.515 to $79.50, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.51 to $80.35, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.58 to $80.67, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.